Active Implants
Active Implants develops the NUsurface Meniscus Implant, the first artificial meniscus prosthesis, targeting orthopedic patients with damaged meniscus tissue as a bridge between meniscus repair and total knee replacement. It is a private Memphis-based medical device company selling investigational hardware to hospitals and clinics.
- Company typePrivate
- Founded2004
- HeadquartersMemphis, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Active Implants does
Active Implants, LLC is a privately held orthopedic medical device company headquartered in Memphis, Tennessee, founded in 2004. The company develops the NUsurface Meniscus Implant, the first commercial 'artificial meniscus' — a prosthetic device designed to replace a damaged or deteriorating natural meniscus in the knee. The product is positioned as a treatment bridge between minimally invasive meniscus repair and total knee replacement, targeting orthopedic patients with intermediate-stage meniscus damage who wish to delay or avoid full knee replacement.
The core technology is a mechanical meniscus prosthesis inserted into the knee joint, with clinical positioning supported by patient education materials, video testimonials, and a dedicated consumer-facing website (nusurfaceimplant.com). The device is classified as investigational and is explicitly not approved for distribution in the United States and its territories, indicating that any current commercial activity is restricted to ex-US clinical or early-adopter settings.
Active Implants operates a hardware sales revenue model, selling implants through orthopedic departments of hospitals and clinics via direct enterprise sales, with a go-to-market motion aimed at orthopedic surgeons and referring physicians. The company has raised approximately $127M across multiple venture rounds since inception, with disclosed investors including LS Health Science Partners, River Street Management, and View Capital RIA. Leadership includes Ted Davis (President & CEO) and J. Michael Keenan (VP Administration & CFO), supported by a small team of 11–50 employees.
Active Implants firmographics
Firmographics- Name
- Active Implants
- Legal name
- Active Implants
- Website
- https://activeimplants.com
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Active Implants develops the NUsurface Meniscus Implant, the first artificial meniscus prosthesis, targeting orthopedic patients with damaged meniscus tissue as a bridge between meniscus repair and total knee replacement. It is a private Memphis-based medical device company selling investigational hardware to hospitals and clinics.
- Ownership category
- akta.pro rank
Active Implants industry classification
Industry- Product category
- Orthopedic Implants
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Sports Medicine & Soft Tissue Repair Implants (Anchors/Grafts/Meniscal Repair) (HLAHAEAF)
- akta.pro secondary industry
- Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA)
Keywords
Where Active Implants is headquartered
LocationHeadquarters
- HQ city
- Memphis
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Active Implants business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure, Others
Revenue model
- Medical Device Sales: Sale of prosthetic meniscus implants to hospitals, orthopedic clinics, and medical institutions. Revenue generated through product sales to healthcare providers performing knee meniscus replacement procedures.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
Active Implants product offering
Product offeringCore offering
Active Implants develops and manufactures the NUsurface® Meniscus Implant, an investigational artificial meniscus device designed to replace a damaged or deteriorating natural meniscus in the knee. The implant is positioned as a treatment bridge between minimally invasive meniscus repair and total knee replacement surgery, intended for orthopedic patients whose meniscus damage is too severe for repair but who wish to delay or avoid full knee replacement. The device is investigational and not approved for distribution in the United States.
Product overview
Active Implants offers the NUsurface® Meniscus Implant, which is the company's sole product offering. The NUsurface® is an investigational artificial meniscus device designed to replace damaged or deteriorating natural meniscus tissue in the knee. The product is positioned as a treatment bridge between minimally invasive meniscus repair and total knee replacement surgery, aimed at patients seeking to return to daily activities sooner with less pain.
Differentiator
Problem solved
Functional benefit
Brands
- NUsurface Meniscus Implant: The first 'artificial meniscus' designed to replace a damaged or deteriorating meniscus. A modern alternative to traditional knee replacement surgery.
Companies that use Active Implants
Customer profileSegments1 record
Ideal customer profiles1 record
Active Implants technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Active Implants partnerships and signals
Strategic signalRecent moves5 records
Expansion highlights3 records
Active Implants competitors and assessment
Company assessmentBroad incumbents
- Smith & Nephew: Smith & Nephew has a major sports medicine and knee reconstruction portfolio, including meniscal repair devices and knee replacement systems. It represents a broad incumbent competitor and potential strategic acquirer of novel meniscus technology.
- Stryker: Stryker is a global orthopedic medical device leader with extensive knee and sports medicine portfolios, including meniscal repair products. While Active Implants competes in the same clinical space, Stryker serves as a broad incumbent that could acquire or compete against NUsurface if it gains commercial traction.
- Arthrex: Arthrex is a privately held leader in sports medicine and orthopedic implants, particularly strong in meniscal repair and arthroscopic solutions. It is a broad incumbent in the same clinical specialty that Active Implants targets.
Direct peers
- ConforMIS: ConforMIS manufactures patient-specific knee replacement implants and partial knee solutions. Both companies are knee-focused orthopedic implant developers targeting improved outcomes versus standard knee replacement, though ConforMIS focuses on patient-specific arthroplasty.
- Anika Therapeutics: Anika Therapeutics develops hyaluronic acid-based joint preservation therapies and regenerative solutions for orthopedic applications, including cartilage and meniscus-related treatments. Both companies pursue non-total-knee-replacement alternatives for joint pain and meniscus damage in active patient populations.
- Vericel: Vericel develops advanced cellular therapies and sports medicine products, including cartilage repair (MACI) for knee cartilage defects. Both companies serve orthopedic surgeons treating patients with knee joint damage seeking joint preservation alternatives to total knee replacement.
- Cartiva Inc. Cartiva developed a synthetic cartilage implant for joint surfaces (initially the great toe, with broader orthopedic applications explored). Like Active Implants, Cartiva pursued novel synthetic implant technology as an alternative to fusion or replacement in joint preservation.
- Moximed: Moximed develops implantable joint unloader devices for the knee, addressing an intermediate treatment population similar to Active Implants' bridge positioning between conservative care and total knee replacement. Both target orthopedic surgeons with novel knee implants for active patients seeking joint preservation.
Emerging players
- Treace Medical Concepts: Treace Medical Concepts commercializes novel orthopedic implants for foot and ankle conditions, representing an emerging orthopedic implant company with a similar commercial-stage profile to where Active Implants aims to reach.
- OrthoPediatrics: OrthoPediatrics is a focused orthopedic implant company addressing specific patient populations (pediatrics) with specialized implant systems. Like Active Implants, it demonstrates the model of a smaller focused orthopedic implant company building a niche commercial business.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
Active Implants social profiles
Digital presenceActive Implants compliance and trust
Trust signalCompliance1 record
Active Implants financial estimates
Financial estimateRevenue estimate
Valuation estimate
Active Implants leadership team
Management profileNumber of profiles
Profiles4 records
Active Implants funding detail
Funding detailFunding overview
Funding rounds14 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Active Implants M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Active Implants
What does Active Implants do?
Active Implants develops and manufactures the NUsurface® Meniscus Implant, an investigational artificial meniscus device designed to replace a damaged or deteriorating natural meniscus in the knee. The implant is positioned as a treatment bridge between minimally invasive meniscus repair and total knee replacement surgery, intended for orthopedic patients whose meniscus damage is too severe for repair but who wish to delay or avoid full knee replacement. The device is investigational and not approved for distribution in the United States.
Is Active Implants a public or private company?
Active Implants is a private company. It is classified as venture growth investor backed and is currently operating.
When was Active Implants founded?
Active Implants was founded in 2004. It employs 11 to 50 people.
Where is Active Implants based?
Active Implants is headquartered in Memphis, United States, in the North America region.
How does Active Implants make money?
One revenue line is on record: medical Device Sales.
Who are Active Implants's main competitors?
Broad incumbents on record are Smith & Nephew, Stryker and Arthrex. Direct peers are ConforMIS, Anika Therapeutics, Vericel, Cartiva Inc. and Moximed. Emerging players are Treace Medical Concepts and OrthoPediatrics.
Does Active Implants have an API?
No public API is recorded for Active Implants.
What industry is Active Implants in?
Active Implants's product category is Orthopedic Implants. Its primary akta.pro industry code is HLAHAEAF, Sports Medicine & Soft Tissue Repair Implants (Anchors/Grafts/Meniscal Repair), with a secondary code of HLAHAEAA, Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle). Its NAICS code is 339113 and its SIC code is 3842.